Showing results (401-410 of 801) with videos related to
Sort By:
Pageof 81
Journal of Alzheimer'S Disease Reports|May 23, 2023
Plasma Biomarkers of Alzheimer's Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical PracticeMarcos V Pais, Orestes V Forlenza, Breno S DinizJournal of Alzheimer'S Disease Reports|May 30, 2020
Sildenafil for the Treatment of Alzheimer's Disease: A Systematic ReviewOwen SandersJournal of Alzheimer'S Disease Reports|May 13, 2021
Amyloid-β Oligomers Induce Only Mild Changes to Inhibitory Bouton DynamicsMarvin Ruiter, Christine Lützkendorf, Jian Liang, et al.Journal of Alzheimer'S Disease Reports|May 13, 2021
Biological Features of Reversion from Mild Cognitive Impairment to Normal Cognition: A Study of Cerebrospinal Fluid Markers and Brain VolumeKamyar Moradi, Shahriar Faghani, AmirHussein Abdolalizadeh, et al.Journal of Alzheimer'S Disease Reports|May 13, 2021
Does Informant-Based Reporting of Cognitive Decline Correlate with Age-Adjusted Hippocampal Volume in Mild Cognitive Impairment and Alzheimer's Disease?Marwan Sabbagh, Justin Miller, Stephen Jones, et al.Journal of Alzheimer'S Disease Reports|September 13, 2021
Alzheimer's Disease Progressively Reduces Visual Functional Network ConnectivityJie Huang, Paul Beach, Andrea Bozoki, et al.Journal of Alzheimer'S Disease Reports|September 13, 2021
Plasma Neurofilament Light and Future Declines in Cognition and Function in Alzheimer's Disease in the FIT-AD TrialDanni Li, Lin Zhang, Nathaniel W Nelson, et al.Journal of Alzheimer'S Disease Reports|August 9, 2021
The Importance of Diagnosing and the Clinical Potential of Treating Obstructive Sleep Apnea to Delay Mild Cognitive Impairment and Alzheimer's Disease: A Special Focus on Cognitive PerformanceMariana Fernandes, Fabio Placidi, Nicola Biagio Mercuri, et al.Journal of Alzheimer'S Disease Reports|December 30, 2021
Computational Approaches for Supporting Combination Therapy in the Post-Aducanumab Era in Alzheimer's DiseaseHugo Geerts, Piet van der GraafJournal of Alzheimer'S Disease Reports|December 6, 2021
Corpus Callosum Atrophy in Detection of Mild and Moderate Alzheimer's Disease Using Brain Magnetic Resonance Image Processing and Machine Learning TechniquesSubhrangshu Das, Priyanka Panigrahi, Saikat ChakrabartiPageof 81